Cargando…
Case Report: Afatinib-Induced Interstitial Pneumonia: Experiences and Lessons From Two Patients
Background: Afatinib has shown good efficacy in patients harboring uncommon EGFR mutations, but the incidence of afatinib-induced interstitial pneumonia should be alert as its rapid progression. Here, we report two cases of interstitial pneumonia during afatinib treatment. Case presentation: The fir...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548719/ https://www.ncbi.nlm.nih.gov/pubmed/34721009 http://dx.doi.org/10.3389/fphar.2021.698447 |